Trevi Therapeutics TRVI
NASDAQ TRVI
$14.18 -0.14 (-0.98%)
At close: Oct 1, 2026 · 4:00 PM EDT

Trevi Therapeutics (TRVI) Accumulated Depreciation (2018 - 2025)

Updated

Trevi Therapeutics' Accumulated Depreciation was $359,000 in Q4 2025, up 57.5% from $228,000 a year earlier.

Analysis

Trevi Therapeutics (TRVI) Accumulated Depreciation (2018 - 2025) Analysis & Trends

From Q4 2018 onward, Trevi Therapeutics has reported Accumulated Depreciation for 8 quarters.

  • Accumulated Depreciation shows a five-year compound annual growth rate of 22.2% (FY2020 to FY2025).
  • In earlier years, Accumulated Depreciation was $228,000 in FY2024 (+70.1%), $134,000 in FY2023 (-40.4%), $225,000 in FY2022 (+23.6%) and $182,000 in FY2021 (+37.9%).
  • The Q4 2025 figure marks the highest quarterly Accumulated Depreciation in data going back to Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Trevi Therapeutics 2.04 Bn 2.04 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 359,000.00
Dec 31, 2024 228,000.00
Dec 31, 2023 134,000.00
Dec 31, 2022 225,000.00
Dec 31, 2021 182,000.00
Dec 31, 2020 132,000.00
Dec 31, 2019 85,000.00
Dec 31, 2018 46,000.00
API Access

Trevi Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=TRVI&period=max&api_key=YOUR_API_KEY